What is the story about?
Amber Enterprises Ltd. reported its fourth quarter earnings on Saturday, May 16.
The company reported a positive set of numbers that were largely above estimates.
Amber Enterprises reported a net profit of ₹134 crore above a CNBC-TV18 poll's ₹129 crore. It was also 15.3% more than last year's ₹116.07 crore.
Its revenue increased 10.5% to ₹4,147.52 crore from ₹3,753.7 crore last year. However, it was below Street expectations of ₹4,238 crore.
The company's earnings before interest, tax, depreciation and amortization (EBITDA) increased 21.5% to ₹358.23 crore from the previous year's ₹294.76 crore. It is also above Street estimates of ₹330 crore.
Its margins expanded to 8.6% from 7.9% in the year-ago period and was above the poll of 7.8%.
The company's electronics segment revenue increased 20.6% to ₹1,015 crore.
Shares of Amber Enterprises India Ltd. ended the previous session 2.8% up at ₹8,519.5 apiece. The stock has risen 10.4% in the past month and 32.1% this year, so far.
Also Read: Dr Reddy's Laboratories launches generic semaglutide injection in Canada
The company reported a positive set of numbers that were largely above estimates.
Amber Enterprises reported a net profit of ₹134 crore above a CNBC-TV18 poll's ₹129 crore. It was also 15.3% more than last year's ₹116.07 crore.
Its revenue increased 10.5% to ₹4,147.52 crore from ₹3,753.7 crore last year. However, it was below Street expectations of ₹4,238 crore.
The company's earnings before interest, tax, depreciation and amortization (EBITDA) increased 21.5% to ₹358.23 crore from the previous year's ₹294.76 crore. It is also above Street estimates of ₹330 crore.
Its margins expanded to 8.6% from 7.9% in the year-ago period and was above the poll of 7.8%.
The company's electronics segment revenue increased 20.6% to ₹1,015 crore.
Shares of Amber Enterprises India Ltd. ended the previous session 2.8% up at ₹8,519.5 apiece. The stock has risen 10.4% in the past month and 32.1% this year, so far.
Also Read: Dr Reddy's Laboratories launches generic semaglutide injection in Canada
/images/ppid_59c68470-image-177877506344624054.webp)
/images/ppid_59c68470-image-177874752746021617.webp)
/images/ppid_59c68470-image-177868504001687038.webp)
/images/ppid_59c68470-image-177885760870916123.webp)
/images/ppid_59c68470-image-177885503396667695.webp)
/images/ppid_59c68470-image-177876256569885323.webp)
/images/ppid_59c68470-image-177885755041243940.webp)
/images/ppid_59c68470-image-177884514433328588.webp)
/images/ppid_59c68470-image-177874756952589792.webp)
/images/ppid_59c68470-image-17788475904763150.webp)
/images/ppid_59c68470-image-1778757570168857.webp)
/images/ppid_59c68470-image-177876261949990552.webp)